WallStreetZenWallStreetZen

NASDAQ: TNDM
Tandem Diabetes Care Inc Earnings & Revenue

TNDM past revenue growth

How has TNDM's revenue growth performed historically?
Company
-6.68%
Industry
9.1%
Market
17.86%
TNDM's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
TNDM's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
TNDM's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

TNDM earnings and revenue history

Current Revenue
$747.7M
Current Earnings
-$222.6M
Current Profit Margin
-29.8%

TNDM Return on Equity

Current Company
-68.7%
Current Industry
10.5%
Current Market
188%
TNDM's Return on Equity (-68.7%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when TNDM announces earnings.

TNDM Return on Assets

Current Company
-23.5%
Current Industry
5.3%
TNDM is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

TNDM Return on Capital Employed

Current Company
-27.78%
Current Industry
8.3%
TNDM's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

TNDM vs Medical Device Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
TNDM$747.72M-$194.66M-$222.61M+32.39%N/A
TMDX$241.62M-$6.66M-$25.03M+79.36%N/A
CNMD$1.24B$136.80M$64.46M+7.68%+7.69%
PRCT$136.19M-$98.08M-$105.90M+116.76%N/A
UFPT$400.07M$68.95M$44.92M+16.00%+24.74%

TNDM earnings dates

Next earnings date
May 1, 2024

Tandem Diabetes Care Earnings & Revenue FAQ

What were TNDM's earnings last quarter?

On Invalid Date, Tandem Diabetes Care (NASDAQ: TNDM) reported Q4 2023 earnings per share (EPS) of -$0.46, up 91.67% year over year. Total Tandem Diabetes Care earnings for the quarter were -$30.00 million. In the same quarter last year, Tandem Diabetes Care's earnings per share (EPS) was -$0.24.

If you're new to stock investing, here's how to buy Tandem Diabetes Care stock.

What was TNDM's earnings growth in the past year?

As of Q1 2024, Tandem Diabetes Care's earnings has grown year over year. Tandem Diabetes Care's earnings in the past year totalled -$222.61 million.

What is TNDM's earnings date?

Tandem Diabetes Care's earnings date is Invalid Date. Add TNDM to your watchlist to be reminded of TNDM's next earnings announcement.

What was TNDM's revenue last quarter?

On Invalid Date, Tandem Diabetes Care (NASDAQ: TNDM) reported Q4 2023 revenue of $196.80 million up 10.75% year over year. In the same quarter last year, Tandem Diabetes Care's revenue was $220.50 million.

What was TNDM's revenue growth in the past year?

As of Q1 2024, Tandem Diabetes Care's revenue has grown -6.68% year over year. This is 15.77 percentage points lower than the US Medical Devices industry revenue growth rate of 9.1%. Tandem Diabetes Care's revenue in the past year totalled $747.72 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.